Chemical formula: C₂₁₅H₃₄₇N₆₁O₆₅S Molecular mass: 4,858.56 g/mol PubChem compound: 131704317
Lixisenatide is indicated for:
Population group: only adults (18 years old or older)
Lixisenatide is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose-lowering medicinal products and/or basal insulin when these, together, with diet and exercise, do not provide adequate glycaemic control
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Lixisenatide is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
